{
    "containers": {
        "cna": {
            "affected": [
                {
                    "defaultStatus": "unaffected",
                    "product": "Patient Information Center iX (PICiX)",
                    "vendor": "Philips",
                    "versions": [
                        {
                            "status": "affected",
                            "version": "B.02"
                        },
                        {
                            "status": "affected",
                            "version": "C.02"
                        },
                        {
                            "status": "affected",
                            "version": "C.03"
                        }
                    ]
                }
            ],
            "credits": [
                {
                    "lang": "en",
                    "type": "finder",
                    "user": "00000000-0000-4000-9000-000000000000",
                    "value": "Julian Suleder, Nils Emmerich, Birk Kauer of ERNW Research GmbH, Dr. Oliver Matula of ERNW Enno, and Rey Netzwerke GmbH reported these vulnerabilities to the Federal Office for Information Security (BSI), Germany, in the context of the BSI project ManiMed (Manipulation of medical devices), which reported these to Philips."
                }
            ],
            "descriptions": [
                {
                    "lang": "en",
                    "supportingMedia": [
                        {
                            "base64": false,
                            "type": "text/html",
                            "value": "<p>\nIn Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, the \nsoftware does not neutralize or incorrectly neutralizes \nuser-controllable input before it is placed in output that is then used \nas a webpage and served to other users. Successful exploitation could \nlead to unauthorized access to patient data via a read-only web \napplication.\n\n</p>"
                        }
                    ],
                    "value": "In Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, the \nsoftware does not neutralize or incorrectly neutralizes \nuser-controllable input before it is placed in output that is then used \nas a webpage and served to other users. Successful exploitation could \nlead to unauthorized access to patient data via a read-only web \napplication.\n\n\n\n"
                }
            ],
            "problemTypes": [
                {
                    "descriptions": [
                        {
                            "cweId": "CWE-79",
                            "description": "CWE-79 Cross-site Scripting",
                            "lang": "en",
                            "type": "CWE"
                        }
                    ]
                }
            ],
            "providerMetadata": {
                "orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
                "shortName": "icscert",
                "dateUpdated": "2023-12-12T20:43:17.263Z"
            },
            "references": [
                {
                    "tags": [
                        "x_refsource_MISC"
                    ],
                    "url": "https://us-cert.cisa.gov/ics/advisories/icsma-20-254-01"
                },
                {
                    "url": "https://www.philips.com/productsecurity"
                }
            ],
            "solutions": [
                {
                    "lang": "en",
                    "supportingMedia": [
                        {
                            "base64": false,
                            "type": "text/html",
                            "value": "\n<p>Philips released the following versions to remediate reported vulnerabilities:</p>\n<ul>\n<li>Patient Information Center iX (PICiX) Version C.03</li>\n<li>Certificate revocation within the system was implemented for PIC iX.</li></ul>\n\n<br>"
                        }
                    ],
                    "value": "Philips released the following versions to remediate reported vulnerabilities:\n\n\n\n  *  Patient Information Center iX (PICiX) Version C.03\n\n  *  Certificate revocation within the system was implemented for PIC iX.\n\n\n\n\n\n"
                }
            ],
            "source": {
                "discovery": "EXTERNAL"
            },
            "title": "Philips Patient Monitoring Devices Cross-site Scripting",
            "workarounds": [
                {
                    "lang": "en",
                    "supportingMedia": [
                        {
                            "base64": false,
                            "type": "text/html",
                            "value": "\n<p>As a mitigation to these vulnerabilities, Philips recommends the following:</p>\n<ul>\n<li>The Philips patient monitoring network is required to be physically \nor logically isolated from the hospital local area network (LAN). \nPhilips recommends using a firewall or routers that can implement access\n control lists restricting access in and out of the patient monitoring \nnetwork for only necessary ports and IP addresses. Refer to the Philips \nPatient Monitoring System Security for Clinical Networks guide for \nadditional information on <a target=\"_blank\" rel=\"nofollow\" href=\"https://incenter.medical.philips.com/\">InCenter</a>.</li>\n<li>By default, the simple certificate enrollment protocol (SCEP) \nservice is not running. When needed, the service is configured to run \nbased on the duration or the number of certificates to be assigned. One \ncertificate is default, but if a certificate is not issued, the service \nwill continue to run. Limit exposure by ensuring the SCEP service is not\n running unless it is actively being used to enroll new devices.</li>\n<li>When enrolling new devices using SCEP, enter a unique challenge password of 8-12 unpredictable and randomized digits.</li>\n<li>Implement physical security controls to prevent unauthorized login \nattempts on the PIC iX application. Servers should be kept in controlled\n locked data centers. Access to equipment at nurses’ stations should be \ncontrolled and monitored.</li>\n<li>Only grant remote access to PIC iX servers on a must-have basis.</li>\n<li>Grant login privileges to the bedside monitor and PIC iX application\n on a role-based, least-privilege basis, and only to trusted users.</li>\n</ul>\n<p>Users with questions regarding their specific Philips Patient \nInformation Center (PIC iX) and/or IntelliVue patient monitor \ninstallations and new release eligibility should contact their local <a target=\"_blank\" rel=\"nofollow\" href=\"https://www.usa.philips.com/healthcare/solutions/customer-service-solutions\">Philips service support team, or regional service support</a>, or call 1-800-722-9377.</p>\n<p>Please see the <a target=\"_blank\" rel=\"nofollow\" href=\"https://www.philips.com/productsecurity\">Philips product security website</a> for the Philips advisory and the latest security information for Philips products.</p>\n\n<br>"
                        }
                    ],
                    "value": "As a mitigation to these vulnerabilities, Philips recommends the following:\n\n\n\n  *  The Philips patient monitoring network is required to be physically \nor logically isolated from the hospital local area network (LAN). \nPhilips recommends using a firewall or routers that can implement access\n control lists restricting access in and out of the patient monitoring \nnetwork for only necessary ports and IP addresses. Refer to the Philips \nPatient Monitoring System Security for Clinical Networks guide for \nadditional information on  InCenter https://incenter.medical.philips.com/ .\n\n  *  By default, the simple certificate enrollment protocol (SCEP) \nservice is not running. When needed, the service is configured to run \nbased on the duration or the number of certificates to be assigned. One \ncertificate is default, but if a certificate is not issued, the service \nwill continue to run. Limit exposure by ensuring the SCEP service is not\n running unless it is actively being used to enroll new devices.\n\n  *  When enrolling new devices using SCEP, enter a unique challenge password of 8-12 unpredictable and randomized digits.\n\n  *  Implement physical security controls to prevent unauthorized login \nattempts on the PIC iX application. Servers should be kept in controlled\n locked data centers. Access to equipment at nurses’ stations should be \ncontrolled and monitored.\n\n  *  Only grant remote access to PIC iX servers on a must-have basis.\n\n  *  Grant login privileges to the bedside monitor and PIC iX application\n on a role-based, least-privilege basis, and only to trusted users.\n\n\n\n\nUsers with questions regarding their specific Philips Patient \nInformation Center (PIC iX) and/or IntelliVue patient monitor \ninstallations and new release eligibility should contact their local  Philips service support team, or regional service support https://www.usa.philips.com/healthcare/solutions/customer-service-solutions , or call 1-800-722-9377.\n\n\nPlease see the  Philips product security website https://www.philips.com/productsecurity  for the Philips advisory and the latest security information for Philips products.\n\n\n\n\n"
                }
            ],
            "x_generator": {
                "engine": "Vulnogram 0.1.0-dev"
            },
            "x_legacyV4Record": {
                "CVE_data_meta": {
                    "ASSIGNER": "ics-cert@hq.dhs.gov",
                    "ID": "CVE-2020-16218",
                    "STATE": "PUBLIC"
                },
                "affects": {
                    "vendor": {
                        "vendor_data": [
                            {
                                "product": {
                                    "product_data": [
                                        {
                                            "product_name": "Philips Patient Information Center iX (PICiX), PerformanceBridge Focal Point, IntelliVue patient monitors MX100, MX400-MX850, and MP2-MP90, IntelliVue X3 and X2.",
                                            "version": {
                                                "version_data": [
                                                    {
                                                        "version_value": "Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, PerformanceBridge Focal Point Version A.01, IntelliVue patient monitors MX100, MX400-MX850, and MP2-MP90 Versions N and prior, IntelliVue X3 and X2 Versions N and prior."
                                                    }
                                                ]
                                            }
                                        }
                                    ]
                                },
                                "vendor_name": "n/a"
                            }
                        ]
                    }
                },
                "data_format": "MITRE",
                "data_type": "CVE",
                "data_version": "4.0",
                "description": {
                    "description_data": [
                        {
                            "lang": "eng",
                            "value": "Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, PerformanceBridge Focal Point Version A.01, IntelliVue patient monitors MX100, MX400-MX850, and MP2-MP90 Versions N and prior, IntelliVue X3 and X2 Versions N and prior. The software does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is then used as a webpage and served to other users. Successful exploitation could lead to unauthorized access to patient data via a read-only web application."
                        }
                    ]
                },
                "problemtype": {
                    "problemtype_data": [
                        {
                            "description": [
                                {
                                    "lang": "eng",
                                    "value": "IMPROPER NEUTRALIZATION OF INPUT DURING WEB PAGE GENERATION ('CROSS-SITE SCRIPTING') CWE-79"
                                }
                            ]
                        }
                    ]
                },
                "references": {
                    "reference_data": [
                        {
                            "name": "https://us-cert.cisa.gov/ics/advisories/icsma-20-254-01",
                            "refsource": "MISC",
                            "url": "https://us-cert.cisa.gov/ics/advisories/icsma-20-254-01"
                        }
                    ]
                }
            }
        }
    },
    "cveMetadata": {
        "assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
        "assignerShortName": "icscert",
        "cveId": "CVE-2020-16218",
        "datePublished": "2020-09-11T12:50:08",
        "dateReserved": "2020-07-31T00:00:00",
        "dateUpdated": "2023-12-12T20:43:17.263Z",
        "state": "PUBLISHED"
    },
    "dataType": "CVE_RECORD",
    "dataVersion": "5.0"
}